Novartis lets Bayer and other suitors see animal-health books

Novartis (NVS) has reportedly opened the books of its animal-health business to Bayer (BAYRY) and other potential suitors so that they can carry out their due diligence.

Novartis' animal-health unit generates sales of $1.1B and that of Bayer $1.7B, so a combination would create the number three or four company in the sector. Zoetis is the industry leader.

From other sites
Comments (1)
  • 166649
    , contributor
    Comments (382) | Send Message
    They should just buy ZTS is #1
    3 Dec 2013, 07:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs